Loading data
ARTVNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 0 USD | 251 k USD | 32.92 m USD |
| Research and development expense | 69.54 m USD | 50.33 m USD | 50.25 m USD |
| Operating profit | -89.81 m USD | -67.28 m USD | -30.67 m USD |
| Profit before tax | — | -65.37 m USD | -28.65 m USD |
| Income tax expense | 0 USD | 0 USD | 72 k USD |
| Net income (reported basis) | -83.87 m USD | -65.37 m USD | -28.72 m USD |
| Basic earnings per share | -3.43 USD/share | -5.81 USD/share | -35.78 USD/share |
| Diluted earnings per share | -3.43 USD/share | -5.81 USD/share | -35.78 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.